U.S. flag

An official website of the United States government

  • delete

NM_000038.6(APC):c.1313-9_1313-6dup AND Familial adenomatous polyposis 1

Germline classification:
Likely benign (1 submission)
Last evaluated:
Mar 1, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004442537.1

Allele description

NM_000038.6(APC):c.1313-9_1313-6dup

Gene:
APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
5q22.2
Genomic location:
Preferred name:
NM_000038.6(APC):c.1313-9_1313-6dup
HGVS:
  • NC_000005.10:g.112821887_112821890dup
  • NG_008481.4:g.134367_134370dup
  • NM_000038.6:c.1313-9_1313-6dupMANE SELECT
  • NM_001127510.3:c.1313-9_1313-6dup
  • NM_001127511.3:c.1259-9_1259-6dup
  • NM_001354895.2:c.1313-9_1313-6dup
  • NM_001354896.2:c.1313-9_1313-6dup
  • NM_001354897.2:c.1343-9_1343-6dup
  • NM_001354898.2:c.1238-9_1238-6dup
  • NM_001354899.2:c.1229-9_1229-6dup
  • NM_001354900.2:c.1136-9_1136-6dup
  • NM_001354901.2:c.1136-9_1136-6dup
  • NM_001354902.2:c.1040-9_1040-6dup
  • NM_001354903.2:c.1010-9_1010-6dup
  • NM_001354904.2:c.935-9_935-6dup
  • NM_001354905.2:c.833-9_833-6dup
  • NM_001354906.2:c.464-9_464-6dup
  • NM_001407446.1:c.1343-9_1343-6dup
  • NM_001407447.1:c.1313-9_1313-6dup
  • NM_001407448.1:c.1313-9_1313-6dup
  • NM_001407449.1:c.1313-9_1313-6dup
  • NM_001407450.1:c.1313-9_1313-6dup
  • NM_001407451.1:c.1238-9_1238-6dup
  • NM_001407452.1:c.1229-9_1229-6dup
  • NM_001407453.1:c.1136-9_1136-6dup
  • NM_001407454.1:c.1010-9_1010-6dup
  • NM_001407455.1:c.1010-9_1010-6dup
  • NM_001407456.1:c.1010-9_1010-6dup
  • NM_001407457.1:c.1010-9_1010-6dup
  • NM_001407458.1:c.1010-9_1010-6dup
  • NM_001407459.1:c.1010-9_1010-6dup
  • NM_001407460.1:c.1010-9_1010-6dup
  • NM_001407467.1:c.926-9_926-6dup
  • NM_001407469.1:c.926-9_926-6dup
  • NM_001407470.1:c.464-9_464-6dup
  • NM_001407471.1:c.161-9_161-6dup
  • NM_001407472.1:c.161-9_161-6dup
  • LRG_130:g.134367_134370dup
  • NC_000005.9:g.112157584_112157587dup
Molecular consequence:
  • NM_000038.6:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001127510.3:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001127511.3:c.1259-9_1259-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354895.2:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354896.2:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354897.2:c.1343-9_1343-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354898.2:c.1238-9_1238-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354899.2:c.1229-9_1229-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354900.2:c.1136-9_1136-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354901.2:c.1136-9_1136-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354902.2:c.1040-9_1040-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354903.2:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354904.2:c.935-9_935-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354905.2:c.833-9_833-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354906.2:c.464-9_464-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407446.1:c.1343-9_1343-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407447.1:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407448.1:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407449.1:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407450.1:c.1313-9_1313-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407451.1:c.1238-9_1238-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407452.1:c.1229-9_1229-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407453.1:c.1136-9_1136-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407454.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407455.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407456.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407457.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407458.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407459.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407460.1:c.1010-9_1010-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407467.1:c.926-9_926-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407469.1:c.926-9_926-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407470.1:c.464-9_464-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407471.1:c.161-9_161-6dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407472.1:c.161-9_161-6dup - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Familial adenomatous polyposis 1 (FAP1)
Synonyms:
POLYPOSIS, ADENOMATOUS INTESTINAL; FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED; APC-Associated Polyposis Conditions
Identifiers:
MONDO: MONDO:0021056; MedGen: C2713442; OMIM: 175100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004930799Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Likely benign
(Mar 1, 2024)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004930799.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024